International cancer patients often struggle to access advanced U.S. expertise due to travel barriers, high costs, and complex hospital systems. This article explores how families can now receive expert guidance from leading U.S. institutions like MD Anderson Cancer Center without leaving their home country.

This article highlights key 2025 advances in pancreatic cancer treatment, including new FDA-approved drugs, targeted therapies, and AI-driven care. It features the real story of Mei Ling, a Stage III patient who accessed a U.S. clinical trial through Medebound HEALTH and achieved curative surgery.